Fundraising Fox
PolyVascular
Houston, US · Delaware corporation
Find your way into PolyVascular
Sign up to see every warm intro you have to PolyVascular
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PolyVascular team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
Founders & leadership
CC
Cindy ClagueVP of Research & Development (PhD)Cindy Clague is VP of Research & Development at PolyVascular, a medical device company developing polymer-based transcatheter pulmonary valves for pediatric congenital heart conditions. She holds a PhD in biomedical engineering and has extensive experience in cardiovascular device development, with 30 issued patents and a background in preclinical evaluation and commercialization of medical technologies.
KB
Katie BalesVP, Investor RelationsKatie Bales is VP of Investor Relations at PolyVascular, a developer of polymer-based transcatheter heart valves for pediatric patients. She previously founded the EverPulse Foundation and brings experience in fundraising across corporate, nonprofit, and venture contexts, alongside expertise in healthcare innovation and health equity initiatives.
PS
Paul SwegleNamed on SEC filing
DH
Daniel HarringtonCo-Founder (PhD)
KC
Kwonsoo ChunNamed on SEC filing
HJ
Henri JustinoCo-Founder (MD)
DS
Doug SmithController
Reported raises · per SEC filings
Form D private placements$795K disclosed across 1 round · 2023
▶$795KraisedJul 2023 · 5 investors · Other Health CareRule 506(b)
▶$795KraisedJul 2023 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul SwegleExecutive Officer
- Daniel HarringtonDirector
- Kwonsoo ChunDirector
- Henri JustinoDirector
- Tim SmokoffExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $795K
- Minimum investment
- $100K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards LifesciencesEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
FoldaxFoldax develops heart valve replacement technology leveraging polymer expertise and biologic design. The company targets patients who require valve replacement, particularly young women with rheumatic disease in developing countries and aging patients in developed markets facing multiple surgeries.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
4C Medical Technologies4C Medical develops minimally invasive medical devices for structural heart disease, including mitral and tricuspid valve treatments. The company serves interventional cardiologists and patients requiring catheter-based cardiac interventions.
Companies working in the same space as PolyVascular.
Frequently asked questions
- What does PolyVascular do?
- PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
- How much funding has PolyVascular raised?
- PolyVascular has disclosed $795K raised across 1 round.
- Where is PolyVascular headquartered?
- PolyVascular is headquartered in Houston, US.